Get started
Author

Tim Asmis

Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
2023 · Jennifer R Eads, Thorvardur R Halfdanarson, et al. · Endocrine Related Cancer · 53
PDF
Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases
2014 · Karim M. Eltawil, Nana Boame, et al. · Journal of Surgical Oncology · 52
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
2010 · T.R. Asmis, E. Powell, et al. · Annals of Oncology · 45
PDF
Risk factors for developing a new venous thromboembolism in ambulatory patients with non‐hematologic malignancies and impact on survival for gastroesophageal malignancies
2010 · M.A. SHAH, M. CAPANU, et al. · Journal of Thrombosis and Haemostasis · 42
The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer
2011 · Rebecca Auer, Adena Scheer, et al. · Blood Coagulation & Fibrinolysis · 27
Uptake and Effectiveness of FOLFIRINOX for Advanced Pancreatic Cancer: a Population-based Study
2017 · S. Karim, J. Zhang-Salomans, et al. · Clinical Oncology · 20
Rechallenge Strategy in Cancer Therapy
2020 · Ekaterina Hanovich, Tim Asmis, et al. · Oncology · 19
An Evidence-Based Guideline for Surveillance of Patients after Curative Treatment for Colon and Rectal Cancer
2022 · Erin Kennedy, Caroline Zwaal, et al. · Current Oncology · 17
PDF
Use of Chemotherapy and Radiofrequency Ablation to Treat Colorectal Cancer Metastases: A Retrospective Review of the Ottawa Hospital Cancer Centre over 7 Years
2014 · N. Boame, G. Gresham, et al. · Current Oncology · 15
PDF
Role of Neoadjuvant Therapy in the Management of Pancreatic Cancer: Is the Era of Biomarker-Directed Therapy Here?
2014 · E.V. Tsvetkova, T.R. Asmis · Current Oncology · 10
PDF
Models of Follow-Up Care and Secondary Prevention Measures for Survivors of Colorectal Cancer: Evidence-Based Guidelines and Systematic Review
2022 · Jacqueline Galica, Caroline Zwaal, et al. · Current Oncology · 7
PDF
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016
2016 · D. Bossé, T. Ng, et al. · Current Oncology · 7
PDF
Pleural and pericardial effusions in patient on tyrosine kinase inhibitor
2017 · Christopher L. Pysyk, Tim Asmis, et al. · Journal of Clinical Anesthesia · 5
Standard Clinical Practice of Folfirinox (Ffx) in Advanced/Metastatic Pancreatic Cancer (Pc) Patients: a Canadian Retrospective Registry
2014 · J.A. Maroun, Y. Ko, et al. · Annals of Oncology · 5
Continuity Clinics in Oncology Training Programs in Canada
2012 · J.M. Croke, M.M. Vickers, et al. · Current Oncology · 5
PDF
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres
2025 · Gautham Nair, Morgan Black, et al. · Current Oncology · 4
PDF
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
2019 · A. J. Hyde, R. Nassabein, et al. · Current Oncology · 4
PDF
Eastern Canadian Colorectal Cancer Consensus Conference: Application of New Modalities of Staging and Treatment of Gastrointestinal Cancers
2012 · T. Di Valentin, Y. Alam, et al. · Current Oncology · 4
PDF
Intervention Development Process for a Pragmatic Randomized Controlled Trial: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial
2019 · Dugald Seely, Julie E. Ennis, et al. · The Journal of Alternative and Complementary Medicine · 2
PDF
Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada
2025 · William J Phillips, Horia Marginean, et al. · Cancer Treatment and Research Communications · 1
LBA82 Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study
2024 · J. Crawford, J.D. Groarke, et al. · Annals of Oncology · 1
PDF
Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
2024 · William J. Phillips, Michelle Pradier, et al. · Current Oncology · 1
PDF
787P Real-world outcomes of organ preservation approach in patients with locally advanced rectal cancer in Canada: Results from the CHORD Consortium
2025 · A.A. Alghamdi, J. Mycek, et al. · Annals of Oncology
Real-World Evaluation of Clinical Outcomes in Patients with Braf-V600e Metastatic Colorectal Cancer (Mcrc)
2025 · William J. Phillips, Horia Marginean, et al. · SSRN Electronic Journal
A Retrospective Analysis of the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors at The Ottawa Hospital Cancer Center over the Last Decade Including COVID-19 Pandemic Period
2024 · Mohammad Alrehaili, William J. Phillips, et al. · Oncology
PDF
Works count: 34
Citation count: 346
H-index: 10
I10-index: 10
Year
Topic
Type